Riposte Capital’s Herbalife HLF Stock Holding History

Riposte Capital’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-240,000	Closed	-$3.57M	–	33
2022 Q4	$3.57M	Buy	+240,000	New	+$4.18M	1%	21

Other funds holding HLF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return

WPL

WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return

ACM

Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return

Riposte Capital's HLF Position: Q1 2023 in Review

Riposte Capital sold out of Herbalife (HLF) in Q1 2023, closing a stake of 240,000 shares — an estimated $3.57M sold.

Riposte Capital first reported a position in HLF in Q4 2022 and held it in 1 quarter. The position peaked at $3.57M in Q4 2022. 210 funds tracked by Wall St. Rank hold HLF as of Q1 2023.

Riposte Capital reported no remaining Herbalife position as of Q1 2023 after selling out during the quarter.
Riposte Capital sold 240,000 Herbalife shares in Q1 2023, an estimated $3.57M.
Riposte Capital first reported a position in Herbalife in Q4 2022 and held it in 1 quarter.
Riposte Capital's Herbalife position peaked at $3.57M in Q4 2022.
210 funds tracked by Wall St. Rank held Herbalife as of Q1 2023.

Based on Riposte Capital's 13F filing for Q1 2023, filed 15 May 2023.